Filing Details
- Accession Number:
- 0001127602-15-017122
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-13 16:27:01
- Reporting Period:
- 2015-05-11
- Filing Date:
- 2015-05-13
- Accepted Time:
- 2015-05-13 16:27:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1395783 | Anthony R Diehl | C/O Insulet Corporation 600 Technology Park Drive, Suite 200 Billerica MA 01821 | Secretary And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-05-11 | 12,500 | $26.63 | 30,837 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-05-11 | 4,482 | $15.09 | 35,319 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-05-11 | 5,535 | $15.16 | 40,854 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-05-11 | 4,482 | $0.00 | 4,482 | $15.09 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-05-11 | 5,535 | $0.00 | 5,535 | $15.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-03-12 | No | 4 | M | Direct | |
| 0 | 2020-03-01 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2014.
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $26.35 to $27.50. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price.
- Includes 5,000 restricted stock units granted on April 1, 2012 which vest on April 1, 2016; 6,250 restricted stock units granted on March 1, 2013 which vest one-half of the total units on March 1, 2016 and one-half of the total units on March 1, 2017; 4,000 performance share units granted on March 1, 2013, which vest on March 1, 2016; 5,334 restricted stock units granted on March 3, 2014 which vest one-half of the total units on March 3, 2016, and one-half of the total units on March 3, 2017; and 10,253 restricted stock units granted on March 2, 2015, which vest one-third of the total units on March 2, 2016, one-third of the total units on March 2, 2017 and one-third of the total units on March 2, 2018. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
- Includes an aggregate of 1,249 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 400 shares acquired on December 31, 2007; and 849 shares acquired on June 30, 2008.
- This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
Billionaire Hedge Funds
